Review Article Online Publishing Date: | ||||||||||||
IJMDC. 2022; 6(6): 864-874 Understanding the pathogenic and nonpathogenic mutations and implications of α-galactosidase variant D313Y in Fabry disease Aly Ezzat, Marwan El Bagoury, Sherif Roushdy, Yahia Aktham.
|
How to Cite this Article |
Pubmed Style Ezzat A, Bagoury ME, Roushdy S, Aktham Y. Understanding the pathogenic and nonpathogenic mutations and implications of α-galactosidase variant D313Y in Fabry disease. IJMDC. 2022; 6(6): 864-874. doi:10.24911/IJMDC.51-1634565050 Web Style Ezzat A, Bagoury ME, Roushdy S, Aktham Y. Understanding the pathogenic and nonpathogenic mutations and implications of α-galactosidase variant D313Y in Fabry disease. https://www.ijmdc.com/?mno=133962 [Access: March 26, 2024]. doi:10.24911/IJMDC.51-1634565050 AMA (American Medical Association) Style Ezzat A, Bagoury ME, Roushdy S, Aktham Y. Understanding the pathogenic and nonpathogenic mutations and implications of α-galactosidase variant D313Y in Fabry disease. IJMDC. 2022; 6(6): 864-874. doi:10.24911/IJMDC.51-1634565050 Vancouver/ICMJE Style Ezzat A, Bagoury ME, Roushdy S, Aktham Y. Understanding the pathogenic and nonpathogenic mutations and implications of α-galactosidase variant D313Y in Fabry disease. IJMDC. (2022), [cited March 26, 2024]; 6(6): 864-874. doi:10.24911/IJMDC.51-1634565050 Harvard Style Ezzat, A., Bagoury, . M. E., Roushdy, . S. & Aktham, . Y. (2022) Understanding the pathogenic and nonpathogenic mutations and implications of α-galactosidase variant D313Y in Fabry disease. IJMDC, 6 (6), 864-874. doi:10.24911/IJMDC.51-1634565050 Turabian Style Ezzat, Aly, Marwan El Bagoury, Sherif Roushdy, and Yahia Aktham. 2022. Understanding the pathogenic and nonpathogenic mutations and implications of α-galactosidase variant D313Y in Fabry disease. International Journal of Medicine in Developing Countries, 6 (6), 864-874. doi:10.24911/IJMDC.51-1634565050 Chicago Style Ezzat, Aly, Marwan El Bagoury, Sherif Roushdy, and Yahia Aktham. "Understanding the pathogenic and nonpathogenic mutations and implications of α-galactosidase variant D313Y in Fabry disease." International Journal of Medicine in Developing Countries 6 (2022), 864-874. doi:10.24911/IJMDC.51-1634565050 MLA (The Modern Language Association) Style Ezzat, Aly, Marwan El Bagoury, Sherif Roushdy, and Yahia Aktham. "Understanding the pathogenic and nonpathogenic mutations and implications of α-galactosidase variant D313Y in Fabry disease." International Journal of Medicine in Developing Countries 6.6 (2022), 864-874. Print. doi:10.24911/IJMDC.51-1634565050 APA (American Psychological Association) Style Ezzat, A., Bagoury, . M. E., Roushdy, . S. & Aktham, . Y. (2022) Understanding the pathogenic and nonpathogenic mutations and implications of α-galactosidase variant D313Y in Fabry disease. International Journal of Medicine in Developing Countries, 6 (6), 864-874. doi:10.24911/IJMDC.51-1634565050 |